Review of 2022 WHO guidelines on the control and elimination of schistosomiasis.

[1]  S. Liang,et al.  Diagnosis of Schistosoma infection in non-human animal hosts: A systematic review and meta-analysis , 2021, PLoS neglected tropical diseases.

[2]  J. Utzinger,et al.  Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study , 2021, The Lancet. Infectious diseases.

[3]  C. Guure,et al.  THE EFFECTIVENESS OF PRAZIQUANTEL PREVENTIVE CHEMOTHERAPY ON MORBIDITY IN SCHISTOSOMIASIS: A SYSTEMATIC REVIEW AND META-ANALYSIS , 2021, medRxiv.

[4]  J. Webster,et al.  Spillover, hybridization, and persistence in schistosome transmission dynamics at the human–animal interface , 2021, Proceedings of the National Academy of Sciences.

[5]  M. Vaillant,et al.  Diagnostic tests for Schistosomiasis for low prevalence settings: a systematic review and Meta-Analysis , 2021, medRxiv.

[6]  J. Utzinger,et al.  Associations between infection intensity categories and morbidity prevalence in school-age children are much stronger for Schistosoma haematobium than for S. mansoni , 2021, PLoS neglected tropical diseases.

[7]  J. Webster,et al.  Schistosomiasis Morbidity Hotspots: Roles of the Human Host, the Parasite and Their Interface in the Development of Severe Morbidity , 2021, Frontiers in Immunology.

[8]  B. Kamel,et al.  Detecting and identifying Schistosoma infections in snails and aquatic habitats: A systematic review , 2021, PLoS neglected tropical diseases.

[9]  M. Chimbari,et al.  A systematic review and meta-analysis quantifying schistosomiasis infection burden in pre-school aged children (PreSAC) in sub-Saharan Africa for the period 2000–2020 , 2020, PloS one.

[10]  T. Naicker,et al.  Clinical morbidity associated with Schistosoma haematobium infection in pre‐school age children from an endemic district in Zimbabwe , 2020, Tropical medicine & international health : TM & IH.

[11]  S. Knopp,et al.  Discovering, Defining, and Summarizing Persistent Hotspots in SCORE Studies , 2020, American Journal of Tropical Medicine and Hygiene.

[12]  J. Utzinger,et al.  Contributions of the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) to Schistosomiasis Control and Elimination: Key Findings and Messages for Future Goals, Thresholds, and Operational Research , 2020, The American journal of tropical medicine and hygiene.

[13]  J. Utzinger,et al.  Characteristics of persistent hotspots of Schistosoma mansoni in western Côte d’Ivoire , 2020, Parasites & Vectors.

[14]  J. Webster,et al.  Schistosomiasis - assessing progress towards the 2020 and 2025 global goals , 2019, The New England journal of medicine.

[15]  E. N'Goran,et al.  Persistent Hotspots in Schistosomiasis Consortium for Operational Research and Evaluation Studies for Gaining and Sustaining Control of Schistosomiasis after Four Years of Mass Drug Administration of Praziquantel , 2019, The American journal of tropical medicine and hygiene.

[16]  P. Hotez,et al.  Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women , 2019, PLoS neglected tropical diseases.

[17]  Haniye Sadat Sajadi,et al.  Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, The Lancet.

[18]  J. Utzinger,et al.  Schistosomiasis , 2018, Nature Reviews Disease Primers.

[19]  S. Brooker,et al.  Schistosomiasis in Africa: Improving strategies for long-term and sustainable morbidity control , 2018, PLoS neglected tropical diseases.

[20]  M. Chase-Topping,et al.  Dynamics of paediatric urogenital schistosome infection, morbidity and treatment: a longitudinal study among preschool children in Zimbabwe , 2018, BMJ Global Health.

[21]  R. Wiegand,et al.  A Persistent Hotspot of Schistosoma mansoni Infection in a Five-Year Randomized Trial of Praziquantel Preventative Chemotherapy Strategies , 2017, The Journal of infectious diseases.

[22]  J. R. Stothard,et al.  Paediatric and maternal schistosomiasis: shifting the paradigms , 2017, British medical bulletin.

[23]  I. Bogoch,et al.  A call to strengthen the global strategy against schistosomiasis and soil-transmitted helminthiasis: the time is now. , 2017, The Lancet. Infectious diseases.

[24]  C. King,et al.  Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis , 2016, PLoS neglected tropical diseases.

[25]  I. Bogoch,et al.  Assessment of global guidelines for preventive chemotherapy against schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study. , 2016, The Lancet. Infectious diseases.

[26]  Kavita Singh,et al.  Association Between Schistosoma haematobium Exposure and Human Immunodeficiency Virus Infection Among Females in Mozambique. , 2016, The American journal of tropical medicine and hygiene.

[27]  C. King,et al.  Systematic Review and Meta-analysis of the Impact of Chemical-Based Mollusciciding for Control of Schistosoma mansoni and S. haematobium Transmission , 2015, PLoS neglected tropical diseases.

[28]  D. Gurarie,et al.  Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa , 2015, Parasites & Vectors.

[29]  I. Bogoch,et al.  Comparison of community-wide, integrated mass drug administration strategies for schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study. , 2015, The Lancet. Global health.

[30]  Mirko S. Winkler,et al.  Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa: a systematic review and geostatistical analysis. , 2015, The Lancet. Infectious diseases.

[31]  C. King,et al.  Historical Perspective: Snail Control to Prevent Schistosomiasis , 2015, PLoS neglected tropical diseases.

[32]  T. Mduluza,et al.  Identifying and Evaluating Field Indicators of Urogenital Schistosomiasis-Related Morbidity in Preschool-Aged Children , 2015, PLoS neglected tropical diseases.

[33]  C. King.  It’s Time to Dispel the Myth of “Asymptomatic” Schistosomiasis , 2015, PLoS neglected tropical diseases.

[34]  M. R. Templeton,et al.  The Relationship between Water, Sanitation and Schistosomiasis: A Systematic Review and Meta-analysis , 2014, PLoS neglected tropical diseases.

[35]  C. King,et al.  Human schistosomiasis , 2014, The Lancet.

[36]  Bernadette A. Thomas,et al.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[37]  T. Ferrari,et al.  Neuroschistosomiasis: clinical symptoms and pathogenesis , 2011, The Lancet Neurology.

[38]  H. Bang,et al.  Urogenital schistosomiasis in women of reproductive age in Tanzania's Lake Victoria region. , 2011, The American journal of tropical medicine and hygiene.

[39]  L. Sandvik,et al.  Association between genital schistosomiasis and HIV in rural Zimbabwean women , 2006, AIDS.